MatchaDB

2018학술 논문무료 열람

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP

Aging

출판사에서 읽기→무료 전문→PubMedPubMed Central

초록

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely unknown. Here, we used MCF7 cells (an ER(+) human breast cancer cell line) as a model system, to systematically dissect the effects of MGT at the cellular level, via i) metabolic phenotyping and ii) unbiased proteomics analysis. Our results indicate that MGT is indeed sufficient to inhibit the propagation of breast cancer stem cells (CSCs), with an IC-50 of ~0.2 mg/ml, in tissue culture. Interestingly, metabolic phenotyping revealed that treatment with MGT is sufficient to suppress both oxidative mitochondrial metabolism (OXPHOS) and glycolytic flux, shifting cancer cells towards a more quiescent metabolic state. Unbiased label-free proteomics analysis identified the specific mitochondrial proteins and glycolytic enzymes that were down-regulated by MGT treatment. Moreover, to discover the underlying signalling pathways involved in this metabolic shift, we subjected our proteomics data sets to bio-informatics interrogation via Ingenuity Pathway Analysis (IPA) software. Our results indicate that MGT strongly affected mTOR signalling, specifically down-regulating many components of the 40S ribosome. This raises the intriguing possibility that MGT can be used as inhibitor of mTOR, instead of chemical compounds, such as rapamycin. In addition, other key pathways were affected, including the anti-oxidant response, cell cycle regulation, as well as interleukin signalling. Our results are consistent with the idea that MGT may have significant therapeutic potential, by mediating the metabolic reprogramming of cancer cells.

초록 텍스트는 PubMed, OpenAlex 또는 Europe PMC에서 가져온 것이며 저자와 출판사에 귀속됩니다.

연구 유형

시험관·세포 연구

세포나 분리된 계에서 이루어진 실험실 실험.

제목, 초록, 주제어에서 자동으로 지정됩니다.

주제

여기서는 말차가 주요 주제입니다(제목에 명시).

키워드와 주제어

내 연구 폴더

이 연구 인용하기

Bonuccelli G, Sotgia F, Lisanti MP. (2018). Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways. Aging. https://doi.org/10.18632/aging.101483

DOI: 10.18632/aging.101483 · PubMed ID: 30153655 · 75회 인용됨 (OpenAlex)

대사와 체중에 대해 더 보기

2020학술 논문

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJ 외 — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

동물 연구대사와 체중장과 마이크로바이옴시장·문화·지속 가능성74회 인용됨
2023학술 논문무료 열람

The therapeutic potential of matcha tea: A critical review on human and animal studies.

Sokary S, Al-Asmakh M, Zakaria Z 외 — Current research in food science

Matcha is a powdered form of Japanese green tea that has been gaining global popularity recently. Matcha tea has various health benefits, including an enhancing effect on cognitive function, cardio-metabolic health, and anti-tumorogenesis.…

리뷰인지 기능·기분·스트레스대사와 체중심혈관과 혈압71회 인용됨

라이브러리 전체 둘러보기→